
Exosome Therapy for Hair: What the Evidence Shows
Exosome therapy is a clinic procedure in which tiny membrane bound particles harvested from cultured cells are applied to the scalp, usually through microneedling channels or fine injections, on the theory that the signalling molecules they carry will influence the hair follicles around them. It is marketed widely in the UK aesthetics market. It is also, at the time of writing, not a licensed medicine in the UK for hair or for anything else cosmetic, and the published human evidence in hair is thin.
Key takeaways
- Exosomes are extracellular vesicles: microscopic packages cells use to send signals to other cells.
- The hair rationale is signalling, not substance. Nothing is being added to the follicle except messages.
- UK regulatory position matters more than the marketing. These are not licensed medicines here.
- Human evidence in hair is small, short and largely industry adjacent. That is not the same as evidence of nothing, but it is not proof either.
- Prices in the UK commonly run into four figures for a course, and courses are usually recommended rather than single sessions.
- The most common reason it disappoints is that the wrong problem was targeted: shedding and breakage do not need signalling molecules.
- Ask what exactly is in the vial, where it was made and what regulatory status it holds, before anything else.
What is exosome therapy, in plain terms?
Exosomes are extracellular vesicles, which is to say very small sacs, typically thirty to a hundred and fifty nanometres across, that cells release into their surroundings. They are not cells and they are not alive. They are packages. Inside them a cell puts proteins, lipids and various forms of RNA, and neighbouring cells take them up and respond to the contents. This is a normal, constant part of how tissue coordinates itself, and it has been an active area of biology for two decades.
Exosome therapy in an aesthetic context takes that biology and productises it. Vesicles are harvested from cultured cells, most often stem cells derived from umbilical or adipose tissue, concentrated into a solution, and applied to the skin or scalp. On the scalp the delivery is usually microneedling, which creates channels for the solution to enter, or a series of shallow injections. A session takes under an hour and is typically sold as a course of three or more.
Why is exosome therapy being offered for hair at all?
The rationale is that the hair follicle is a signalling environment, and that some of the signals which govern whether a follicle is growing or resting are the kind of molecules exosomes carry. Laboratory work on hair follicle cells and animal work in mice have both reported effects on the growth cycle when exosome preparations are introduced. That is a genuine finding and it is why the interest exists.
The gap is the one that swallows most promising ideas in this field. A cell in a dish, and a mouse follicle, are a long way from a human scalp with decades of androgen exposure behind it. Plenty of things that shift a follicle in a laboratory do nothing measurable in a person, and the history of hair research is largely a history of that gap. Interest is not the same as an established result, and it is worth being clear about which one you are being sold.
What does the evidence on exosome therapy for hair actually show?
Honestly, less than the marketing implies, and more than nothing.
The laboratory and animal evidence is reasonably consistent in showing that exosome preparations can influence the behaviour of hair follicle cells. The human evidence is where it thins out. Published human studies in hair tend to be small, often a few dozen participants, usually short, frequently without a control group receiving a dummy version, and often conducted with a commercial interest in the outcome. Photography is a notoriously unreliable endpoint in hair research when the lighting and hair styling are not tightly standardised, and standardisation is exactly what small studies most often skip.
There is also a definitional problem that makes comparing studies difficult. Different providers use different source cells, different isolation methods, different concentrations and different measures of what counts as an exosome at all. Two products both sold as exosome therapy may have very little in common. Where good sources disagree, the disagreement is usually about this: proponents point to the mechanistic and animal work as a reason for optimism, while dermatology bodies point to the absence of large, controlled human trials and to the regulatory position as reasons for caution. Both readings are defensible from the same literature, which is itself a signal about how settled this is.
What is the regulatory position in the UK?
This is the part most worth understanding before any money changes hands, because it is concrete in a way the efficacy question is not.
In the UK, a product made from human cells or their derivatives and used to achieve a physiological effect does not sit in the same category as a cosmetic cream. Depending on how it is made and what is claimed for it, it may fall under medicines regulation, under the rules covering human tissue, or into a borderline category that the Medicines and Healthcare products Regulatory Agency assesses case by case. What it is not is a routine, licensed, off the shelf product with an approved indication for hair. Regulators in other markets have issued public safety communications about unapproved products in this space, and UK professional bodies covering cosmetic practice have raised similar concerns about unlicensed regenerative products being offered in aesthetic clinics.
None of that means a given clinic is acting improperly. It does mean the ordinary consumer assumptions do not apply. There is no approved indication to check, no standard formulation, no published side effect profile of the kind a licensed medicine carries, and the safety net you would normally rely on is thinner than usual. That is a reasonable thing to weigh, and a reasonable thing to ask direct questions about.
Hair loss, hair shedding and hair breakage are three different problems
Before considering any procedure, it is worth being certain which of these you actually have, because the most common reason an expensive intervention disappoints is that it was aimed at the wrong one.
- Hair loss here means follicular miniaturisation, where the follicle survives but produces a progressively finer, shorter hair each cycle. It is gradual and patterned, and it is the problem exosome procedures are pitched at.
- Hair shedding is a cycle event. A large number of follicles enter their resting phase together, usually after illness, surgery, a sharp weight change or childbirth, and release their hairs a few months later. It is diffuse and dramatic, and it resolves on its own. Our explainer on telogen effluvium and sudden shedding covers the timeline.
- Hair breakage is a fibre problem, not a follicle problem. The hair snaps along its length because heat, bleach, colour or tension have weakened it. The hairs in your brush have blunt ends rather than small pale bulbs.
A course of injections aimed at follicle signalling will do nothing for breakage, and shedding would have recovered anyway, which is precisely why post hoc testimonials in this category should be read carefully. If you are not sure which you have, the three clue thinning self check is the place to start, and it costs nothing.
What should you ask a clinic before agreeing to anything?
These are the questions that separate a considered decision from an expensive one. Ask them by email, so the answers are in writing.
- What exactly is in the vial, and who made it? Source cells, manufacturer, country of origin, and batch documentation. A supplier who cannot answer this quickly is telling you something.
- What is its UK regulatory status? Ask directly whether it holds a UK marketing authorisation for this use. Ask for the answer in writing.
- What is the total cost of a full course, not a single session? Courses are the norm and single session pricing is rarely the real number.
- What happens if nothing changes? Ask what the policy is, before rather than after.
- How will the result be measured? Standardised photography at fixed distance, angle and lighting, or nothing. Casual before and after photographs are the least reliable evidence in this entire field.
- What has been ruled out first? Thyroid function, ferritin and other correctable causes are cheap to check and are a common reason for diffuse thinning. A provider who has not asked about them is not looking hard.
Get a discount on your next order
Join the Watermans mailing list and we will email a discount code straight to your inbox. Vegan, made in the UK, over 5 million bottles sold since 2012.
What is worth doing before spending on a procedure?
Sequence matters here more than almost anything else, because the cheap steps are also the ones most likely to explain what is happening.
- Get the correctable causes checked. Thyroid function and ferritin are simple blood tests. Low iron stores and thyroid imbalance are common, correctable, and produce exactly the diffuse thinning that gets attributed to something else.
- Establish a baseline you can trust. Photographs of the same parting, same angle, same daylight, eight weeks apart. Without this you cannot judge any intervention, paid or free.
- Work out the pattern. A widening central parting with an intact hairline is a different picture from even shedding across the whole head, and our guide to what causes thinning hair walks through the alternatives.
- Fix the mechanical damage first. If heat, bleach or tension are snapping your hair, no amount of follicle signalling will show through, because the length is being lost after it grows.
- Speak to your GP about anything fast moving. A change that has happened over weeks rather than years, or any patch of completely smooth bare scalp, should be looked at rather than injected.
Where does everyday cosmetic hair care fit?
Nowhere near the same category, and it is worth being straight about that rather than implying otherwise.
Cosmetic hair care does not act on follicle signalling and it is not an alternative to a clinic procedure. What it does is protect the hair you already have, which matters more than people expect on a scalp where each strand is finer than it used to be. Fine hair snaps under handling that coarser hair survives, and every strand lost to breakage takes length and apparent density with it. That is a real, modest, honest benefit, and it is the only one being claimed here.
Watermans products are 100% cosmetic and do not treat medical hair loss. Individual results may vary.
A sulfate free everyday cleanse with biotin, caffeine and rosemary, formulated to support a comfortable scalp environment and leave fine hair looking fuller. Cosmetic, and priced like it.
Condition Me Hair Growth Conditioner
Slip is what lets a comb pass without force, and fine hair snaps under force coarser hair would shrug off. If breakage is doing part of the work, this is the cheapest place to stop it.
Frequently asked questions
Is exosome therapy approved in the UK?
Not as a licensed medicine for hair. Products of this kind sit under medicines, human tissue or borderline product rules depending on how they are made and what is claimed, and they are assessed case by case rather than carrying a routine approval for cosmetic or hair use. Ask any provider for their product's UK regulatory status in writing.
How much does exosome therapy cost in the UK?
Pricing varies widely by clinic and by product, and it is almost always sold as a course rather than a single session, so the meaningful figure is the total course price. UK courses commonly reach four figures. Always ask for the full course cost before comparing anything.
Is exosome therapy the same as PRP?
No. Platelet rich plasma uses a concentrate made from your own blood, drawn and spun on the day. Exosome preparations are manufactured from cultured cells that are not yours, which is precisely why the regulatory questions are different and more involved.
Does the procedure hurt?
Reports vary with the delivery method. Microneedling delivery is usually described as uncomfortable rather than painful, and topical numbing is common. Scalp tenderness and redness for a day or two afterwards are the commonly reported after effects.
How long before anything would be visible?
Any change in hair takes months, whatever produced it, because hair grows roughly a centimetre a month and a follicle has to complete its cycle before new growth becomes visible. Anybody promising visible change in weeks is describing something other than hair biology.
Who is exosome therapy least likely to help?
Anyone whose actual problem is breakage, and anyone in the middle of a temporary shedding episode that was going to recover anyway. Both groups are well represented in this market, and both are why the testimonials are hard to read.
Is exosome therapy safe?
There is no licensed safety profile to point to, which is the honest answer. Because the products are unlicensed for this use and vary between suppliers, the usual documentation you would rely on for a medicine does not exist in the same form. Discuss it with a qualified clinician who is not selling it to you.
What should I do first if my hair is thinning?
Speak to your GP, get thyroid function and ferritin checked, work out whether you are dealing with loss, shedding or breakage, and take standardised photographs so you have a baseline. Those four steps cost very little and change what any later decision should be.
The bottom line
Exosome therapy for hair is an interesting idea with real laboratory support, sold in a market where the regulatory framework has not caught up and the human evidence has not been established. That combination should make anyone slow down rather than stop reading. Get the cheap, correctable causes ruled out first, be certain which of loss, shedding and breakage you actually have, insist on written answers about what is in the vial and what its UK status is, and judge any result on standardised photographs rather than on how the mirror looks on a good day.
Sources & References
- Medicines and Healthcare products Regulatory Agency, guidance on borderline products and on how products derived from human cells are assessed against medicines legislation in the UK.
- U.S. Food and Drug Administration, public safety communications on unapproved regenerative medicine products, including preparations marketed as exosome products.
- Joint Council for Cosmetic Practitioners, public position statements on unlicensed regenerative and injectable products offered in aesthetic practice in the UK.
- British Association of Dermatologists, public information leaflets on male and female pattern hair loss and on telogen effluvium.
- NICE Clinical Knowledge Summaries, alopecia scenario guidance, on the investigations commonly considered for diffuse hair thinning including thyroid function and ferritin.

















